Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
15.33
-0.39 (-2.48%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Janux Therapeutics Employees
Janux Therapeutics had 108 employees as of March 31, 2026. The number of employees decreased by 1 or -0.92% since the number was last reported on December 31, 2025.
Employees
108
Change
-1
Growth
-0.92%
Revenue / Employee
$127,157
Profits / Employee
-$1,059,981
Market Cap
934.89M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 108 | -1 | -0.92% |
| Dec 31, 2025 | 109 | 28 | 34.57% |
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Dec 31, 2023 | 64 | 4 | 6.67% |
| Dec 31, 2022 | 60 | 27 | 81.82% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Phathom Pharmaceuticals | 371 |
| Kura Oncology | 260 |
| Geron | 258 |
| Sana Biotechnology | 142 |
| Olema Pharmaceuticals | 137 |
| Lexicon Pharmaceuticals | 81 |
| Inventiva | 77 |
JANX News
- 4 weeks ago - Janux Therapeutics assumed with a Buy at Truist - TheFly
- 4 weeks ago - Janux Therapeutics reports departure of Chief Medical Officer - TheFly
- 2 months ago - Janux Therapeutics price target lowered to $22 from $23 at Evercore ISI - TheFly
- 2 months ago - Janux Therapeutics price target lowered to $36 from $45 at Wedbush - TheFly
- 2 months ago - Janux Therapeutics price target lowered to $26 from $30 at Piper Sandler - TheFly
- 2 months ago - Janux Therapeutics reports Q1 EPS (39c), consensus (52c) - TheFly
- 2 months ago - Janux Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
- 2 months ago - Janux Therapeutics Earnings release: Q1 2026 - Filings